{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:38:02Z","timestamp":1788687482634,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["Vici Grant (09150181910040)"],"award-info":[{"award-number":["Vici Grant (09150181910040)"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02060-w","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:08:29Z","timestamp":1747120109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling the paradox: cardiovascular risk profiling in migraine\u2013 a correspondence"],"prefix":"10.1186","volume":"26","author":[{"given":"Linda","family":"Al-Hassany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben W. A.","family":"van Drie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre M.","family":"Boucherie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"MaassenVanDenBrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"3","key":"2060_CR1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41591-025-03533-w","volume":"31","author":"NA Marston","year":"2025","unstructured":"Marston NA, Kamanu FK, Melloni GEM, Schnitzler G, Hakim A, Ma RX et al (2025) Endothelial cell-related genetic variants identify LDL cholesterol-sensitive individuals who derive greater benefit from aggressive lipid lowering. Nat Med 31(3):963\u2013969","journal-title":"Nat Med"},{"key":"2060_CR2","doi-asserted-by":"crossref","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z, Lifting The Burden: the Global Campaign against Headache. Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020 Dec 2;21(1):137.","DOI":"10.1186\/s10194-020-01208-0"},{"issue":"3","key":"2060_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020498","volume":"8","author":"AN Mahmoud","year":"2018","unstructured":"Mahmoud AN, Mentias A, Elgendy AY, Qazi A, Barakat AF, Saad M et al (2018) Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open 8(3):e020498","journal-title":"BMJ Open"},{"issue":"22","key":"2060_CR4","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1001\/jama.2020.7172","volume":"323","author":"T Kurth","year":"2020","unstructured":"Kurth T, Rist PM, Ridker PM, Kotler G, Bubes V, Buring JE (2020) Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women. JAMA 323(22):2281\u20132289","journal-title":"JAMA"},{"issue":"7","key":"2060_CR5","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/STROKEAHA.116.016133","volume":"48","author":"HJA van Os","year":"2017","unstructured":"van Os HJA, Mulder IA, Broersen A, Algra A, van der Schaaf IC, Kappelle LJ et al (2017) Migraine and cerebrovascular atherosclerosis in patients with ischemic stroke. Stroke 48(7):1973\u20131975","journal-title":"Stroke"},{"issue":"8","key":"2060_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.amjmed.2006.03.023","volume":"119","author":"B Ahmed","year":"2006","unstructured":"Ahmed B, BaireyMerz CN, McClure C, Johnson BD, Reis SE, Bittner V et al (2006) Migraines, angiographic coronary artery disease and cardiovascular outcomes in women. Am J Med 119(8):670\u2013675","journal-title":"Am J Med"},{"issue":"4","key":"2060_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209700","volume":"103","author":"L Al-Hassany","year":"2024","unstructured":"Al-Hassany L, Acarsoy C, Ikram MK, Bos D, MaassenVanDenBrink A (2024) Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study. Neurology 103(4):e209700","journal-title":"Neurology"},{"issue":"4","key":"2060_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11916-018-0682-8","volume":"22","author":"A Iljazi","year":"2018","unstructured":"Iljazi A, Ayata C, Ashina M, Hougaard A (2018) The role of endothelin in the pathophysiology of migraine-a systematic review. Curr Pain Headache Rep 22(4):27","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"2060_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1129-2377-14-80","volume":"14","author":"S Sacco","year":"2013","unstructured":"Sacco S, Ripa P, Grassi D, Pistoia F, Ornello R, Carolei A et al (2013) Peripheral vascular dysfunction in migraine: a review. J Headache Pain 14(1):80","journal-title":"J Headache Pain"},{"key":"2060_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.06.078","volume":"384","author":"L Al-Hassany","year":"2023","unstructured":"Al-Hassany L, Linstra KM, Meun C, van den Berg J, Boersma E, Danser AHJ et al (2023) Decreased role of neuropeptides in the microvascular function in migraine patients with polycystic ovary syndrome. Atherosclerosis 384:117172","journal-title":"Atherosclerosis"},{"issue":"3","key":"2060_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(21)00409-9","volume":"21","author":"L Al-Hassany","year":"2022","unstructured":"Al-Hassany L, Goadsby PJ, Danser AHJ, MaassenVanDenBrink A (2022) Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions. Lancet Neurol 21(3):284\u2013294","journal-title":"Lancet Neurol"},{"issue":"1","key":"2060_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s10194-023-01567-4","volume":"24","author":"L Al-Hassany","year":"2023","unstructured":"Al-Hassany L, Boucherie DM, Creeney H, van Drie RWA, Farham F, Favaretto S et al (2023) Future targets for migraine treatment beyond CGRP. J Headache Pain 24(1):76","journal-title":"J Headache Pain"},{"issue":"16","key":"2060_CR13","doi-asserted-by":"publisher","first-page":"E1899","DOI":"10.1212\/WNL.0000000000007313","volume":"92","author":"GLJ Onderwater","year":"2019","unstructured":"Onderwater GLJ, Ligthart L, Bot M, Demirkan A, Fu J, Van Der Kallen CJH et al (2019) Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine. Neurology 92(16):E1899\u2013E1911","journal-title":"Neurology"},{"issue":"1","key":"2060_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/head.14039","volume":"61","author":"I Liampas","year":"2021","unstructured":"Liampas I, Mylonas KS, Brotis A, Dervenis P, Siokas V, Mentis AFA et al (2021) Serum lipid abnormalities in migraine: A meta-analysis of observational studies. Headache 61(1):44\u201359","journal-title":"Headache"},{"key":"2060_CR15","doi-asserted-by":"crossref","unstructured":"Ibrahimi K, Rist PM, Carpenet C, Lee Rohmann J, Buring JE, Maassen van den Brink A, et al. Vascular Risk Score and Associations With Past, Current, or Future Migraine in Women: Cohort Study. Neurology. 2022 Aug 19;99(16):e1694\u2013701.","DOI":"10.1212\/WNL.0000000000201009"},{"issue":"1","key":"2060_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10194-025-01957-w","volume":"26","author":"HA Makhlouf","year":"2025","unstructured":"Makhlouf HA, Hassan AK, Almosilhy NA, Osman ASA, Ramadan S, Abouelmagd ME (2025) Exploring the association between statins use or HMG-CoA reductase inhibition and migraine: a systematic review and meta-analysis. J Headache Pain 26(1):23","journal-title":"J Headache Pain"},{"issue":"1","key":"2060_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s10194-023-01633-x","volume":"24","author":"Y Bi","year":"2023","unstructured":"Bi Y, Zhu Y, Tang S, Huang Y (2023) Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study. J Headache Pain 24(1):112","journal-title":"J Headache Pain"},{"issue":"8","key":"2060_CR18","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/ph17081056","volume":"17","author":"HS Kang","year":"2024","unstructured":"Kang HS, Kim JH, Kim JH, Bang WJ, Yoo DM, Lee NE, Han KM, Kim NY, Choi HG, Min KW, Kwon MJ (2024) The Association between Statin Use and Reduced Migraine Likelihood: A Comprehensive Analysis of Migraine Subtypes and Statin Types in a Nationwide Korean Cohort. Pharmaceuticals (Basel) 17(8):1056","journal-title":"Pharmaceuticals (Basel)"},{"key":"2060_CR19","doi-asserted-by":"crossref","unstructured":"Al-Hassany L, Boucherie DM, Creeney H, van Drie RWA, Farham F, Favaretto S, et al. on behalf of the European Headache Federation School of Advanced Studies (EHF-SAS). Future targets for migraine treatment beyond CGRP. J Headache Pain. 2023 Jun 28;24(1):76.","DOI":"10.1186\/s10194-023-01567-4"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02060-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02060-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02060-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:08:32Z","timestamp":1747120112000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-02060-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2060"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02060-w","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Linda Al-Hassany, Ruben W.A. van Drie, and Deirdre M. Boucherie declare that they had no conflict of interest with respect to the research, authorship, and\/or publication of this article. Antoinette MaassenVanDenBrink received research grants and\/or consultation fees from AbbVie, Amgen\/Novartis, Eli Lilly, Lundbeck, Manistee, Pfizer, Satsuma, Teva, and Tonix.Antoinette MaassenVanDenBrink received research grants and\/or consultation fees from AbbVie, Amgen\/Novartis, Eli Lilly, Lundbeck, Manistee, Pfizer, Satsuma, Teva, and Tonix.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}